DAERS Production Training Presentation

January 6, 2018 | Author: Anonymous | Category: Engineering & Technology, Computer Science, Networking
Share Embed Donate


Short Description

Download DAERS Production Training Presentation...

Description

Division of AIDS Data Interchange

DAIDS ADVERSE EXPERIENCE REPORTING SYSTEM (DAERS) PRODUCTION TRAINING

Last Updated: 4/7/2010

v1.60 - Rev.2

1

Division of AIDS Data Interchange

Agenda DAIDS-ES Overview DAERS

DAERS Training and Account Information Workflow Selected Features DAERS Terminology Submission Timelines DAERS Changes per new EAE Manual Version 2.0

Maintenance of User Account Information DAERS Additional Information DAERS Contact Information Training Demonstration

Last Updated: 4/7/2010

v1.60 - Rev.2

2

Division of AIDS Data Interchange What is the DAIDS-ES? The DAIDS Enterprise System (DAIDS-ES) is a suite of tools, built on a common framework that enhances clinical research by supporting scientific, administrative and regulatory processes. This enterprise system contains multiple integrated modules for key business areas. DAERS is a Secure, Confidential Web-based system that supports Therapeutic, Vaccines and Prevention EAE Reporting

CSM is the single source for all monitoring information that supports standardization of findings and visit reports across networks and non-networks

DPRS supports the Electronic Submission and tracking of registration materials

Last Updated: 4/72010

v1.60 - Rev.2

3

Division of Account AIDS Dataand Interchange DAERS Training Information Site Leaders or Site Coordinators must submit a request to DAIDS-ES Support for access to DAERS for all new users through the Site Enrollment module. All Submitters who attend training must also submit the following information to attain access to DAERS: Physician Electronic Signature Attestation Form This form and directions on how to complete and send it may be found on RCC’s website: http://rcc.techres.com/safetyandpharmacovigilance/

Completion of training and submission of forms does not automatically generate user account for DAERS. RCC must verify Submitters against the FDA Form 1572/IoR Agreements on file and that the CRS is Protocol Registered for all the protocols listed in the request for access. At least 1 submitter must be trained at a site before account information is sent. Last Updated: 4/7/2010

v1.60 - Rev.2

4

Division of AIDS Data Interchange High Level DAERS Workflow Stop No

Clinical Research Site (CRS)

AE Occurs at CRS

Review EAE submission RCC

DAERS – EAE Reporting

Report to RCC?

Yes

Additional Information Required?

Create EAE

Submit EAE to RCC

Update EAE

Sends Query to CRS

Yes

Archive Report

Notify FDA & CRS

No Yes Assess EAE Report

Additional Information Required?

No No

Safety Report Required?

Yes

Create Safety Report

DAIDS

Last Updated: 9/15/2009

v1.55 - Rev.1

5

DAERS (EAE Reporting) Selected Features Division of AIDS Data Interchange Secure, Confidential, Web-based system Assess the reportability of an adverse event Create, Submit and Update EAE reports to RCC electronically Instant access to EAE reports Built-in checks and list of values

Protocols CRSs Participant IDs Study Interventions

Supports EAE Reporting to the Division of AIDS E-mail notification of EAE report submission to CRS Staff and other key stakeholders. Last Updated: 4/7//2010

v1.60 - Rev.2

6

Division of AIDS Data Interchange DAERS Terminology Roles Reporter – Site study staff who have the ability to create EAE reports. Submitter – Study Physician(s) who have the ability to create, sign and submit EAE reports. • To be a submitter, a physician: – Must be listed on the FDA 1572 form or Investigator of Record Agreement. – Must sign the Physician Electronic Signature Attestation Form – Must be formally trained on the DAERS system

EAE Report Types Initial – Original EAE report sent to RCC. Update – Once an EAE report has been submitted to RCC, additional information is submitted through an update.

Last Updated: 4/7/2010

v1.60 - Rev.2

7

Division of AIDS Data Interchange DAERS Terminology (cont) EAE Report Statuses Pending

Ready for Final Review

An EAE report has been started by the Reporter or Submitter, but it has not been finished.

The EAE report contains all required elements and is ready to be reviewed by the Study Physician.

Submitted to RCC

Withdrawn

The Study Physician has approved and sent the EAE report to RCC.

An EAE Report erroneously submitted to RCC, which is no longer considered an official EAE submission.

Reporter, Submitter or RCC

Status Definition

Email Notification Recipient

To: Reporter for EAE, Study Coordinator

Last Updated: 4/7/2010

To: Reporter for EAE, All Study Physicians on protocol at site, Study Coordinator

v1.60 - Rev.2

To: RCC, Submitter, Reporter for EAE, All Study Physicians on protocol at site, Study Coordinator, Network’s DMC, and Site’s ICC (where applicable).

To: Reporter or Submitter requesting withdrawal.

8

of AIDS Data Interchange DAERSDivision Terminology (cont)

Unique 6 digit number assigned when report is created Indicates the year the report was submitted

Last Updated: 4/7/2010

v1.60 - Rev.2

Created

Submitted

Indicates the version of the updated report created

Updated

Indicates the RCCassigned EAE number prior to the migration

Legacy Migrated 9

Division of AIDS Data Interchange Submission Timelines EAE Reports are required to be signed and submitted within three reporting days of the site awareness date. Monday through Friday count as reporting days. Holidays that occur on a Monday through Friday count as reporting days. Saturday and Sunday are considered non-reporting days. Reporting days are counted in local time. A reporting day starts at 12:00 am and ends at 11:59 pm. A day is counted as a reporting day regardless of the time of the day that awareness occurred prior to 11:59 pm. The site awareness day shall count as the first reporting day unless it occurs on a non-reporting day (i.e., Saturday or Sunday); in which case, the next reporting day shall count as the first reporting day. Any EAE submitted after the third reporting day shall be considered late.

Last Updated: 4/7/2010

v1.60 - Rev.2

10

of AIDS Data Interchange SubmissionDivision Timelines (cont) Example: Site Awareness: March 13th at 2:00 PM Report Submission Due: March 17th at 11:59 PM

March Sunday

Monday

Tuesday

Wednesday

Thursday

Friday

Saturday

1

2

3

4

5

6

7

8

9

10

11

12

13 Site

14

15

Awareness (2:00pm local time)

16

17

18

19

20

21

22

23 30

24 31

25

26

27

28

29

Last Updated: 4/7/2010

Report Due (11:59pm local time )

v1.60 - Rev.2

11

of AIDS Data Interchange Past DueDivision Submission Reports that are not submitted within the three reporting days will require an explanation for the delay in submission

Last Updated: 4/7/2010

v1.60 - Rev.2

12

of AIDS Data Interchange SubmissionDivision Timelines (cont)

The Alerts web part on the DAERS home screen allows users to quickly identify EAE reports that are either approaching their due date or past their due date.

Last Updated: 4/7/2010

v1.60 - Rev.2

13

Division of AIDS Data Interchange DAERS Changes per EAE Manual Version 2.0

All new protocols will be using the EAE Manual Version 2.0 For existing protocols, sites will be notified by their protocol teams if your protocols will be required to switch to the EAE Manual Version 2.0 DAERS will automatically reflect the changes once a protocol using the EAE Manual Version 2.0 is selected. Last Updated: 4/7/2010

v1.60 - Rev.2

14

Division of AIDS Data Interchange DAERS Changes per EAE Manual Version 2.0 After a protocol has switched to the EAE Manual Version 2.0: Updates to EAE reports created prior to the switch will continue using EAE Manual Version 1.0 Initial EAEs will use EAE Manual Version 2.0 regardless of the Protocol Version it is reported against

Switch Submitted Initial EAE

Update EAE

EAE Manual Version 1.0

EAE Manual Version 1.0

Created Initial EAE

Submit Initial EAE

EAE Manual Version 1.0

EAE Manual Version 1.0

Create Initial EAE EAE Manual Version 2.0 Last Updated: 4/7/2010

v1.60 - Rev.2

15

ofAccount AIDS Data Interchange MaintenanceDivision of User Information

Adding Users to DAERS The Site Leader or Coordinator must request access for site staff using the Site Enrollment Module in DAERS. • Must provide the following information for each added site staff: – User’s Name and contact information (email, phone, fax) – DAERS Role by Protocol

All new users must complete training. Reporters • Will only have access to report EAEs on protocols that have at least one Physician who also has access to submit EAEs on those protocols.

Submitters • Must mail the Electronic Signature attestation from to the RCC. • Must be listed on the FDA Form 1572 or IoR Agreement. Last Updated: 4/7/2010

v1.60 - Rev.2

16

Division of AIDS Data Interchange Maintenance of User Account Information Site Leaders and Site Coordinators are responsible for maintaining their DAERS User’s Information through the Site Enrollment Module. This includes the following scenarios: Adding new users to DAERS • When additional people join the organization, sites must follow the process to add users to DAERS.

Access to newly registered Protocols • When a site registers to a new EAE reporting DAIDS protocol, the Site Leader or Site Coordinator must request access for the users who have been identified for the role of Submitter or Reporter for that particular protocol, and submit the associated documentation to DAIDS-ES Support. (Physician Electronic Signature Attestation Form - If the submitter is not a current user of the DAERS system)

Adding access rights • When a site user requires Reporter access to additional protocols, the Site Leader or Site Coordinator is responsible for modifying this information. • When a site user requires Submitter access to additional protocols, Site Leader or Site Coordinator is responsible for modifying this information based off the FDA Form 1572/ IoR Agreement.

Removal of Access • When a user leaves the site’s organization or is no longer on a protocol, Site Leader or Site Coordinator is responsible for modifying this information.

Last Updated: 3/26/2010

v1.60 - Rev.1

17

DAERS Additional Information Division of AIDS Data Interchange Instructions and necessary documents are found on the RCC website http://rcc.techres.com/safetyandpharmacovigilance/

If additional training is required the site should contact DAIDS-ES Support. [email protected] Last Updated: 4/7/2010

v1.60 - Rev.2

18

Division of AIDS Data Information Interchange DAERS Contact

Questions about … DAIDS EAE Manual or DAIDS Reporting Requirements

DAERS

E-Mail:

E-mail:

Phone:

Phone:

Fax:

Fax:

[email protected]

1-800-537-9979 (USA) +1-301-897-1709 (International) 1-800-275-7619 (USA) +1-301-897-1710 (International)

[email protected]

1-866-337-1605 (USA) + 1-240-499-2239 (International) 1-866-337-1606 (USA) + 1-301-948-2242 (International)

When in doubt, copy both. Last Updated: 4/7/2010

v1.60 - Rev.2

19

of AIDS Data Interchange Training Division Demonstration Assessment of an Adverse Event EAE Report Generation and Submission Creating an EAE Report Completing an EAE Report Submitting an EAE Report (Only available to Submitter)

Updating an EAE Report Updating an EAE Report

Search EAE Report Features Searching EAE Reports Viewing/Modifying an EAE Report Deleting an EAE Report Copying an EAE ReportNew!

Additional Features Online Help DAIDS-ES Support

Site Enrollment Module (Site Leaders and Site Coordinators only) New! Submit New Request View Existing Requests

Adding EAE Notification Recipients (Site Leaders and Site Coordinators only) New!

Last Updated: 4/7/2010

v1.60 - Rev.2

20

NIAID, Division of AIDS

Appendix – Changes in DAERS per EAE Manual Version 2.0 by Field

Division of AIDS Data Interchange DAERS Changes per New EAE Manual Version 2.0 Field and EAE Report Section

EAE Manual Version 1.0

New EAE Manual Version 2.0

AE Reporting Method (Assessment Tool)

• EAE

• SAE (Serious Adverse Event) • SUSAR (Suspected, Unexpected Serious Adverse Reactions)

Level of Reporting (Assessment Tool)

• Standard, Targeted, Intensive

• No Longer Displayed

Relationship to Study Product/Protoc ol (Assessment Tool, Study Agents/Vaccine s)

• • • • • •

Definitely Related Probably Related Possibly Related Probably Not Related Not Related Pending (temporary assignment for death)

• Related • Not Related

Expectedness (Assessment Tool)

• Required for protocols with a Targeted Level of Reporting

• Expected • Unexpected

Last Updated: 4/7/2010

v1.60 - Rev.2

22

Division of AIDS Data Interchange DAERS Changes per New EAE Manual Version 2.0 Field and EAE Report Section

EAE Manual Version 1.0

New EAE Manual Version 2.0

Country of AE Origin (Primary Adverse Event)

• N/A

• Drop down list that displays all Countries. • User selects country where the event occurred.

Seriousness Criteria (Assessment Tool, Primary Adverse Event)

• Death • Life-threatening • Hospitalization or prolongation of existing hospitalization • Persistent or significant disability/incapacity • Congenital anomaly/birth defect • None of the above, but is a protocolspecific reporting requirement, including Grade 3 events as required by the Intensive level • None of the above, but is of sufficient concern to report to DAIDS

• Results in Death • Is life-threatening • Requires inpatient hospitalization or prolongation of existing hospitalization • Results in persistent or significant disability/incapacity • Is a congenital anomaly/birth defect • Other important medical event that may jeopardize the subject or that may require intervention to prevent outcomes listed above • None of the above, this is not an SAE, but is a protocol-specific reporting requirement • None of the above, this is not an SAE, but is of sufficient concern to report to DAIDS

Last Updated: 4/7/2010

v1.60 - Rev.2

23

View more...

Comments

Copyright � 2017 NANOPDF Inc.
SUPPORT NANOPDF